ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan · Delayed Price · Currency is TWD 19.10
+0.05 (0.26%)
Aug 28, 2026, 1:30 PM CST
ScinoPharm Taiwan Market Cap
ScinoPharm Taiwan has a market cap or net worth of 15.1 billion as of August 28, 2026. Its market cap has increased by 4.09% in one year.
Market Cap
15.10B
Enterprise Value
12.48B
Revenue
3.07B
Ranking
n/a
PE Ratio
400.32
Stock Price
19.10
ChartMarket Cap Chart
Since October 29, 2010, ScinoPharm Taiwan's market cap has decreased from 30.44B to 15.10B, a decrease of -50.38%. That is a compound annual growth rate of -4.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 15.10B | 14.03% |
| Dec 31, 2025 | 13.24B | -24.04% |
| Dec 31, 2024 | 17.44B | -16.48% |
| Dec 29, 2023 | 20.88B | 3.73% |
| Dec 30, 2022 | 20.12B | 3.25% |
| Dec 30, 2021 | 19.49B | -14.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 25.36B |
| TTY Biopharm Company | 19.37B |
| Synmosa Biopharma | 16.14B |
| YungShin Global Holding | 14.86B |
| Grape King Bio | 13.35B |
| Handa Pharmaceuticals | 12.62B |
| Foresee Pharmaceuticals | 12.51B |
| Standard Chemical & Pharmaceutical | 10.20B |